Presented ByProf. Amer Zeidan, Yale University, CT, USA
ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:19
Presented ByDr David Sallman, Moffitt Cancer Center, FL, USA
TrialPhase 3, ENHANCE ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:19
Presented ByDr Anne Sophie Kubasch, University of Leipzig, Germany
TrialPhase 2, RELAZA2 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:19
Presented ByProf. Nicholas Short, University of Texas, TX, USA
ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 11:25
Presented ByProf. Naval Daver, Anderson Cancer Center, TX, USA
TrialPhase 3, ENHANCE-3 ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 11:17
Presented ByDr Naval Daver, MD Anderson Cancer Center, TX, USA
TrialPhase 1/2 ConferenceASH 2021
TypePeer-reviewed article
4 February 2022 11:49
Presented ByDr Patrick Reville, MD Anderson Cancer Center, TX, USA
TrialPhase 2 ConferenceASH 2021
TypePeer-reviewed article
4 February 2022 11:48
Presented ByDr David Sallman, H. Lee Moffitt Cancer Center, FL, USA
TrialPhase 2 ConferenceASH 2021
TypePeer-reviewed article
4 February 2022 11:44
Presented ByDr Rachel Giles, Medicom
ConferenceASH 2021
4 January 2022 08:00
Presented ByProf. Hartmut Döhner, Universitätsklinikum Ulm, Germany
TrialPhase 2, QUAZAR AML-001 ConferenceEHA 2021
TypePeer-reviewed article
5 August 2021 13:59
Presented ByDr Courtney Di Nardo, MD Anderson Cancer Centre, USA
TrialPhase 3, VIALE-A ConferenceEHA 2020
TypePeer-reviewed article
9 September 2020 13:25
Presented ByProf. Naval Draver, University of Texas MD Anderson Cancer Centre, USA
TrialPhase 1 ConferenceEHA 2020
TypePeer-reviewed article
9 September 2020 13:14
Presented ByDr Courtney Di Nardo, MD Anderson Cancer Centre, USA
TrialPhase 2, AG-221-AML-005 ConferenceEHA 2020
TypePeer-reviewed article
9 September 2020 12:55
Presented ByProf. Adrian Ochsenbein, Bern University Hospital, Switzerland
ConferenceASH 2019
TypePeer-reviewed article
5 March 2020 17:01
Presented ByProf. Uwe Platzbecker, University Hospital Carl Gustav Carus, Germany
TrialPhase 2, RELAZA2 ConferenceASH 2019
TypePeer-reviewed article
5 March 2020 16:04
